Precision targeting of MET in NSCLC: A multidisciplinary approach
40:57
Expanding HER2 horizons: Implications for NSCLC and beyond
27:28
Precision targeting of MET in NSCLC: A multidisciplinary approach
39:16
Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors
51:31
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
17:53
La Increíble Ingeniería de las Resonancias Magnéticas
52:18
¿UNA DIETA PUEDE CURAR EL CÁNCER?
50:50
Ep.13 🔸 La microbiota del Mago More
35:54